Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AGIO |
---|---|---|
09:32 ET | 4302 | 43.075 |
09:34 ET | 200 | 43.005 |
09:36 ET | 100 | 42.99 |
09:38 ET | 304 | 42.805 |
09:39 ET | 1452 | 42.87 |
09:41 ET | 100 | 42.9575 |
09:43 ET | 300 | 42.95 |
09:45 ET | 1300 | 42.86 |
09:48 ET | 500 | 43.03 |
09:50 ET | 500 | 43.185 |
09:52 ET | 100 | 43.11 |
09:54 ET | 200 | 42.98 |
09:56 ET | 4798 | 42.96 |
09:57 ET | 4430 | 43.115 |
09:59 ET | 900 | 43 |
10:03 ET | 600 | 42.66 |
10:06 ET | 1500 | 42.673 |
10:08 ET | 300 | 42.72 |
10:10 ET | 200 | 42.695 |
10:12 ET | 200 | 42.52 |
10:14 ET | 1266 | 42.31 |
10:15 ET | 100 | 42.38 |
10:17 ET | 100 | 42.28 |
10:19 ET | 300 | 42.22 |
10:21 ET | 3470 | 42.7 |
10:24 ET | 3574 | 42.96 |
10:26 ET | 800 | 42.99 |
10:28 ET | 703 | 42.945 |
10:30 ET | 1300 | 42.98 |
10:32 ET | 331 | 42.9668 |
10:33 ET | 200 | 42.925 |
10:35 ET | 300 | 43.05 |
10:37 ET | 352 | 43.14 |
10:39 ET | 594 | 43.115 |
10:42 ET | 100 | 43.18 |
10:44 ET | 100 | 43.16 |
10:46 ET | 1100 | 42.87 |
10:48 ET | 200 | 43.05 |
10:50 ET | 300 | 43 |
10:51 ET | 322 | 42.99 |
10:53 ET | 799 | 42.915 |
10:55 ET | 1400 | 43.04 |
10:57 ET | 200 | 42.95 |
11:00 ET | 300 | 43.055 |
11:04 ET | 400 | 43.09 |
11:06 ET | 800 | 42.91 |
11:08 ET | 600 | 42.84 |
11:09 ET | 200 | 42.82 |
11:11 ET | 700 | 42.815 |
11:13 ET | 700 | 42.735 |
11:15 ET | 200 | 42.695 |
11:18 ET | 1200 | 42.82 |
11:20 ET | 100 | 42.815 |
11:22 ET | 400 | 42.815 |
11:24 ET | 500 | 42.815 |
11:26 ET | 1400 | 42.86 |
11:27 ET | 1600 | 42.855 |
11:29 ET | 100 | 42.85 |
11:31 ET | 2200 | 42.955 |
11:33 ET | 100 | 42.955 |
11:36 ET | 1200 | 42.855 |
11:38 ET | 2029 | 42.8775 |
11:40 ET | 100 | 42.875 |
11:42 ET | 1503 | 42.766 |
11:44 ET | 500 | 42.76 |
11:45 ET | 300 | 42.755 |
11:47 ET | 800 | 42.71 |
11:49 ET | 400 | 42.75 |
11:51 ET | 300 | 42.545 |
11:54 ET | 100 | 42.55 |
11:56 ET | 500 | 42.525 |
11:58 ET | 600 | 42.58 |
12:00 ET | 773 | 42.57 |
12:02 ET | 400 | 42.49 |
12:03 ET | 100 | 42.44 |
12:05 ET | 1204 | 42.45 |
12:07 ET | 200 | 42.44 |
12:09 ET | 1007 | 42.515 |
12:12 ET | 1100 | 42.57 |
12:14 ET | 700 | 42.5 |
12:16 ET | 400 | 42.36 |
12:18 ET | 100 | 42.35 |
12:21 ET | 600 | 42.35 |
12:23 ET | 1600 | 42.34 |
12:25 ET | 200 | 42.44 |
12:30 ET | 4186 | 42.23 |
12:32 ET | 700 | 42.21 |
12:34 ET | 617 | 42.08 |
12:36 ET | 528 | 42.09 |
12:38 ET | 3391 | 42.13 |
12:39 ET | 200 | 42.09 |
12:41 ET | 716 | 42.1157 |
12:43 ET | 800 | 42.01 |
12:45 ET | 400 | 41.99 |
12:48 ET | 400 | 41.91 |
12:50 ET | 573 | 41.935 |
12:52 ET | 100 | 41.935 |
12:54 ET | 252 | 41.87 |
12:56 ET | 395 | 41.77 |
12:57 ET | 100 | 41.74 |
12:59 ET | 400 | 41.73 |
01:01 ET | 200 | 41.66 |
01:03 ET | 452 | 41.61 |
01:06 ET | 452 | 41.65 |
01:10 ET | 3971 | 41.735 |
01:12 ET | 100 | 41.82 |
01:15 ET | 811 | 41.74 |
01:17 ET | 800 | 41.76 |
01:19 ET | 100 | 41.76 |
01:21 ET | 400 | 41.73 |
01:24 ET | 400 | 41.76 |
01:28 ET | 350 | 41.65 |
01:30 ET | 1904 | 41.74 |
01:32 ET | 300 | 41.66 |
01:33 ET | 300 | 41.7 |
01:37 ET | 1600 | 41.7 |
01:39 ET | 900 | 41.89 |
01:42 ET | 1012 | 41.79 |
01:44 ET | 400 | 41.75 |
01:48 ET | 400 | 41.61 |
01:50 ET | 547 | 41.56 |
01:51 ET | 1000 | 41.7 |
01:53 ET | 100 | 41.63 |
01:55 ET | 400 | 41.67 |
01:57 ET | 805 | 41.68 |
02:00 ET | 400 | 41.66 |
02:02 ET | 839 | 41.62 |
02:04 ET | 1803 | 41.78 |
02:09 ET | 300 | 41.83 |
02:11 ET | 300 | 41.76 |
02:13 ET | 500 | 41.765 |
02:15 ET | 600 | 41.81 |
02:18 ET | 100 | 41.76 |
02:20 ET | 300 | 41.765 |
02:22 ET | 517 | 41.71 |
02:24 ET | 100 | 41.72 |
02:26 ET | 300 | 41.73 |
02:27 ET | 600 | 41.7 |
02:29 ET | 1300 | 41.62 |
02:31 ET | 2340 | 41.76 |
02:36 ET | 600 | 41.81 |
02:38 ET | 1158 | 41.895 |
02:40 ET | 300 | 41.89 |
02:42 ET | 800 | 41.86 |
02:44 ET | 800 | 41.89 |
02:45 ET | 100 | 41.895 |
02:47 ET | 200 | 41.895 |
02:49 ET | 2142 | 41.83 |
02:51 ET | 605 | 41.73 |
02:54 ET | 200 | 41.77 |
02:56 ET | 3064 | 41.84 |
02:58 ET | 1328 | 41.92 |
03:00 ET | 500 | 41.865 |
03:02 ET | 200 | 41.87 |
03:03 ET | 500 | 41.875 |
03:05 ET | 900 | 41.785 |
03:07 ET | 561 | 41.735 |
03:09 ET | 3257 | 41.78 |
03:12 ET | 700 | 41.73 |
03:14 ET | 345 | 41.68 |
03:16 ET | 1185 | 41.72 |
03:18 ET | 3643 | 41.84 |
03:20 ET | 200 | 41.835 |
03:21 ET | 1730 | 41.8 |
03:23 ET | 100 | 41.805 |
03:25 ET | 1416 | 41.775 |
03:27 ET | 500 | 41.755 |
03:30 ET | 2200 | 41.825 |
03:32 ET | 500 | 41.82 |
03:34 ET | 3030 | 41.79 |
03:36 ET | 2462 | 41.83 |
03:38 ET | 8744 | 41.77 |
03:39 ET | 2900 | 41.78 |
03:41 ET | 350 | 41.71 |
03:43 ET | 2734 | 41.635 |
03:45 ET | 2000 | 41.62 |
03:48 ET | 3804 | 41.71 |
03:50 ET | 2910 | 41.725 |
03:52 ET | 4338 | 41.85 |
03:54 ET | 6101 | 41.84 |
03:56 ET | 8429 | 41.96 |
03:57 ET | 11707 | 41.93 |
03:59 ET | 22427 | 42.05 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Agios Pharmaceuticals Inc | 2.4B | -6.7x | --- |
Celldex Therapeutics Inc | 2.4B | -13.0x | --- |
IDEAYA Biosciences Inc | 2.6B | -16.9x | --- |
Geron Corp | 2.5B | -12.0x | --- |
Intellia Therapeutics Inc | 2.1B | -4.1x | --- |
Apogee Therapeutics Inc | 2.2B | -18.7x | --- |
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering transformative therapies for patients living with rare diseases. It markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for debilitating hemolytic anemia. Its lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes. In addition, it is also evaluating mitapivat for the treatment of alpha- and beta- thalassemia and sickle cell disease (SCD) in ongoing clinical trials. The Company is also developing AG-946, a clinical-stage oral activator of PKR enzymes for the treatment of hemolytic anemias and other indications, including SCD.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.4B |
---|---|
Revenue (TTM) | $29.4M |
Shares Outstanding | 56.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.78 |
EPS | $-6.31 |
Book Value | $14.50 |
P/E Ratio | -6.7x |
Price/Sales (TTM) | 81.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,336.42% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.